These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35889310)

  • 41. Development and validation of GC-MS method for the determination of methyl methanesulfonate and ethyl methanesulfonate in imatinib mesylate.
    Ramakrishna K; Raman NV; Rao KM; Prasad AV; Reddy KS
    J Pharm Biomed Anal; 2008 Mar; 46(4):780-3. PubMed ID: 18178357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analytical method validation for terbutryn using gas chromatography/ion trap, gas chromatography/mass selective detector, and liquid chromatography/triple quadrupole mass spectrometers.
    Jang HW; Lee J; Choi H; Nam TG; Kim SH; Lee KG
    Food Sci Biotechnol; 2018 Oct; 27(5):1525-1530. PubMed ID: 30319864
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Automated statistical experimental design approach for rapid separation of coenzyme Q10 and identification of its biotechnological process related impurities using UHPLC and UHPLC-APCI-MS.
    Talluri MV; Kalariya PD; Dharavath S; Shaikh N; Garg P; Ramisetti NR; Ragampeta S
    J Sep Sci; 2016 Sep; 39(18):3528-35. PubMed ID: 27488256
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trace determination of mutagenic alkyl toluenesulfonate impurities via derivatization headspace-GC/MS in an active pharmaceutical ingredient of a candidate drug.
    Liu XW; Zhang WP; Han HY; Sun L; Chen DY
    J Pharm Biomed Anal; 2018 Jun; 155():104-108. PubMed ID: 29626717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gas chromatography with mass spectrometric, atomic emission and Fourier transform infrared spectroscopic detection as complementary analytical techniques for the identification of unknown impurities in pharmaceutical analysis.
    Laniewski K; Wännman T; Hagman G
    J Chromatogr A; 2003 Jan; 985(1-2):275-82. PubMed ID: 12580495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and validation of a specific and sensitive GC-FID method for the determination of impurities in 5-chlorovaleroyl chloride.
    Tang L; Kim A; Miller SA; Lloyd DK
    J Pharm Biomed Anal; 2010 Nov; 53(3):309-14. PubMed ID: 20439146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of multiple impurities in a pharmaceutical matrix using preparative gas chromatography and computer-assisted structure elucidation.
    Codina A; Ryan RW; Joyce R; Richards DS
    Anal Chem; 2010 Nov; 82(21):9127-33. PubMed ID: 20942391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid and simultaneous determination of sulfonate ester genotoxic impurities in drug substance by liquid chromatography coupled to tandem mass spectrometry: comparison of different ionization modes.
    Guo T; Shi Y; Zheng L; Feng F; Zheng F; Liu W
    J Chromatogr A; 2014 Aug; 1355():73-9. PubMed ID: 24997109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification, isolation, characterization, and UHPLC quantification of potential genotoxic impurities in linagliptin.
    Huang Y; Lu H; Zhang F; Min C
    J Sep Sci; 2018 Nov; 41(21):3985-3994. PubMed ID: 30155968
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impurity analysis of pure aldrin using heart-cut multi-dimensional gas chromatography-mass spectrometry.
    Li X; Dai X; Yin X; Li M; Zhao Y; Zhou J; Huang T; Li H
    J Chromatogr A; 2013 Feb; 1277():69-75. PubMed ID: 23332869
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Determination of potentially genotoxic impurities in crotamiton active pharmaceutical ingredient by gas chromatography.
    Kalauz A; Kapui I
    J Pharm Biomed Anal; 2022 Feb; 210():114544. PubMed ID: 34968997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective quantitation of B
    Shamirian A; Foti C; Mitchell SS
    J Pharm Biomed Anal; 2021 May; 198():113987. PubMed ID: 33684830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Optimization and evaluation of low-pressure gas chromatography-mass spectrometry for the fast analysis of multiple pesticide residues in a food commodity.
    Mastovská K; Lehotay SJ; Hajslová J
    J Chromatogr A; 2001 Aug; 926(2):291-308. PubMed ID: 11556334
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities.
    Kovarich S; Cappelli CI
    Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HPLC-MS Analysis of Four Potential Genotoxic Impurities in Alogliptin Pharmaceutical Materials.
    Al-Sabti B; Harbali J
    J AOAC Int; 2022 Mar; 105(2):362-369. PubMed ID: 34849990
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of quality-by-design analytical methods.
    Vogt FG; Kord AS
    J Pharm Sci; 2011 Mar; 100(3):797-812. PubMed ID: 21280050
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HILIC-MS Determination of Genotoxic Impurity of 2-Chloro-N-(2-Chloroethyl)Ethanamine in the Vortioxetine Manufacturing Process.
    Douša M; Klvaňa R; Doubský J; Srbek J; Richter J; Exner M; Gibala P
    J Chromatogr Sci; 2016 Feb; 54(2):119-24. PubMed ID: 26223463
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of a selective, sensitive and stability indicating UPLC-MS/MS method for rapid, simultaneous determination of six process related impurities in darunavir drug substance.
    A VBR; Yusop Z; Jaafar J; Aris AB; Majid ZA; Umar K; Talib J
    J Pharm Biomed Anal; 2016 Sep; 128():141-148. PubMed ID: 27262107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS.
    Han S; Karłowicz-Bodalska K; Potaczek P; Wójcik A; Ozimek L; Szura D; Musiał W
    AAPS PharmSciTech; 2014 Feb; 15(1):111-20. PubMed ID: 24166667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.